Retour
18
Fourchette du Jour
169,30 €
175,17 €
Fourchette 52 Semaines
163,11 €
315,35 €
Volume
882 842
Moyenne 50J / 200J
204,15 €
/
245,83 €
Clôture Précédente
172,23 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 17,7 | 0,2 |
| P/B | 1,2 | 3,0 |
| ROE % | 7,0 | 3,6 |
| Net Margin % | 0,9 | 3,8 |
| Rev Growth 5Y % | 11,6 | 9,9 |
| D/E | 0,7 | 0,2 |
Objectif de Cours des Analystes
Hold
235,00 €
+34.9%
Low: 146,00 €
High: 345,00 €
P/E Prévisionnel
18,90
BPA Prévisionnel
9,22 €
Croissance BPA (est.)
+0,0%
CA Est.
160,62B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
41,63 €
34,72 € – 45,09 €
|
204,44B | 5 |
| FY2029 |
38,84 €
32,40 € – 42,06 €
|
192,72B | 2 |
| FY2028 |
26,37 €
18,73 € – 35,68 €
|
183,11B | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-11 | -4,00 € | -3,96 € | +1,0% |
| 2025-11-05 | 2,93 € | 3,24 € | +10,6% |
| 2025-07-30 | 5,92 € | 6,27 € | +5,9% |
| 2025-04-30 | 10,07 € | 11,58 € | +15,0% |
| 2025-02-11 | -2,23 € | -2,16 € | +3,1% |
| 2024-10-30 | 3,40 € | 4,16 € | +22,4% |
| 2024-07-31 | 5,85 € | 6,96 € | +19,0% |
| 2024-04-24 | 6,12 € | 7,23 € | +18,1% |
Dividend History
7 yr streakYield
0,01%
Payout Ratio
0,36%
Growth (3Y)
3,95%
Growth (5Y)
7,20%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 27, 2026 | Apr 24, 2026 | 0,89 € | 2,03% |
| Dec 26, 2025 | Jan 30, 2026 | 0,89 € | 1,37% |
| Sep 26, 2025 | Oct 31, 2025 | 0,89 € | 1,39% |
| Jun 27, 2025 | Jul 25, 2025 | 0,89 € | 1,46% |
| Mar 28, 2025 | Apr 25, 2025 | 0,89 € | 1,34% |
| Dec 31, 2024 | Jan 31, 2025 | 0,89 € | 1,40% |
| Sep 30, 2024 | Oct 25, 2024 | 0,89 € | 1,12% |
| Jun 28, 2024 | Jul 26, 2024 | 0,89 € | 0,95% |
| Mar 27, 2024 | Apr 26, 2024 | 0,89 € | 1,01% |
| Dec 28, 2023 | Jan 26, 2024 | 0,89 € | 0,78% |
| Sep 28, 2023 | Oct 27, 2023 | 0,89 € | 0,70% |
| Jun 29, 2023 | Jul 28, 2023 | 0,89 € | 0,75% |
| Mar 30, 2023 | Apr 28, 2023 | 0,89 € | 0,66% |
| Dec 29, 2022 | Jan 27, 2023 | 0,79 € | 0,61% |
| Sep 29, 2022 | Oct 28, 2022 | 0,79 € | 0,62% |
| Jun 29, 2022 | Jul 29, 2022 | 0,79 € | 0,64% |
| Mar 30, 2022 | Apr 29, 2022 | 0,79 € | 0,66% |
| Dec 30, 2021 | Jan 28, 2022 | 0,70 € | 0,60% |
| Sep 29, 2021 | Oct 29, 2021 | 0,70 € | 0,69% |
| Jun 29, 2021 | Jul 30, 2021 | 0,70 € | 0,60% |
Points Clés
Revenue grew 11,58% annually over 5 years — strong growth
Generating 375,00M in free cash flow
Capital efficient — spends only 0,42% of revenue on capex
ROIC of 3,56% — low return on invested capital
Dividends growing 7,20% annually over 5 years
Croissance
Revenue Growth (5Y)
11,58%
Revenue (1Y)10,06%
Earnings (1Y)-1,57%
FCF Growth (3Y)-64,51%
Qualité
Return on Equity
6,98%
ROIC3,56%
Net Margin0,92%
Op. Margin1,12%
Sécurité
Debt / Equity
0,73
Current Ratio0,72
Interest Coverage2,30
Valorisation
P/E Ratio
17,69
Forward P/E18,90
P/B Ratio1,19
EV/EBITDA20,47
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 10,06% | Revenue Growth (3Y) | 10,37% |
| Earnings Growth (1Y) | -1,57% | Earnings Growth (3Y) | -30,91% |
| Revenue Growth (5Y) | 11,58% | Earnings Growth (5Y) | -20,22% |
| Profitability | |||
| Revenue (TTM) | 129,66B | Net Income (TTM) | 1,19B |
| ROE | 6,98% | ROA | 2,44% |
| Gross Margin | 14,54% | Operating Margin | 1,12% |
| Net Margin | 0,92% | Free Cash Flow (TTM) | 375,00M |
| ROIC | 3,56% | FCF Growth (3Y) | -64,51% |
| Safety | |||
| Debt / Equity | 0,73 | Current Ratio | 0,72 |
| Interest Coverage | 2,30 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,36% |
| Dividend Growth (3Y) | 3,95% | Dividend Growth (5Y) | 7,20% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 17,69 | Forward P/E | 18,90 |
| P/B Ratio | 1,19 | P/S Ratio | 0,16 |
| PEG Ratio | -18,57 | Forward PEG | N/A |
| EV/EBITDA | 20,47 | Fwd EV/EBITDA | 4,64 |
| Forward P/S | 0,13 | Fwd Earnings Yield | 5,29% |
| FCF Yield | 1,78% | ||
| Market Cap | 21,01B | Enterprise Value | 29,75B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 129,66B | 117,81B | 106,44B | 92,92B | 83,65B |
| Net Income | 1,19B | 1,21B | 2,49B | 2,81B | 2,93B |
| EPS (Diluted) | 9,84 | 9,98 | 20,00 | 22,08 | 22,67 |
| Gross Profit | 18,85B | 17,15B | 18,05B | 17,23B | 14,45B |
| Operating Income | 1,45B | 1,63B | 3,32B | 3,56B | 3,42B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 48,75B | 46,31B | 46,89B | 43,73B | 44,75B |
| Total Liabilities | 31,01B | 29,87B | 30,57B | 28,36B | 28,65B |
| Shareholders' Equity | 17,66B | 16,38B | 16,26B | 15,31B | 16,08B |
| Total Debt | 12,94B | 12,26B | 12,27B | 11,75B | 13,23B |
| Cash & Equivalents | 4,20B | 2,22B | 4,69B | 5,06B | 3,39B |
| Current Assets | 7,47B | 4,93B | 6,73B | 6,74B | 5,21B |
| Current Liabilities | 10,31B | 11,26B | 11,95B | 11,63B | 10,49B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#478 of 619
Activité Récente
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026